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Abstract
Preeclampsia is a major cause of perinatal mortality and disease affecting 5–10% of all pregnancies worldwide, but its
etiology remains poorly understood despite considerable research effort. Parent-offspring conflict theory suggests that such
hypertensive disorders of pregnancy may have evolved through the ability of fetal genes to increase maternal blood
pressure as this enhances general nutrient supply. However, such mechanisms for inducing hypertension in pregnancy
would need to incur sufficient offspring health benefits to compensate for the obvious risks for maternal and fetal health
towards the end of pregnancy in order to explain why these disorders have not been removed by natural selection in our
hunter-gatherer ancestors. We analyzed .750,000 live births in the Danish National Patient Registry and all registered
medical diagnoses for up to 30 years after birth. We show that offspring exposed to pregnancy-induced hypertension (PIH)
in trimester 1 had significantly reduced overall later-life disease risks, but increased risks when PIH exposure started or
developed as preeclampsia in later trimesters. Similar patterns were found for first-year mortality. These results suggest that
early PIH leading to improved postpartum survival and health represents a balanced compromise between the reproductive
interests of parents and offspring, whereas later onset of PIH may reflect an unbalanced parent-offspring conflict at the
detriment of maternal and offspring health.
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Introduction
Relative to the great apes, humans have long pregnancies and
relatively high perinatal risks for mother and offspring. This
condition is generally perceived as being due to selection for large
fetal brains and constraints on evolutionary responses in the pelvic
bones of adult females because of trade-offs with efficient bipedal
locomotion [1]. Caesarian section and hygienic obstetric practices
have now greatly reduced the risks of giving birth in affluent
societies, and considerable progress has been made in developing
countries. However, advances in understanding pregnancy
complications related to elevated maternal blood pressure, such
as preeclampsia and eclampsia, have been less impressive. These
conditions remain a major cause of maternal and infant morbidity
and mortality, especially in developing countries [2]. Preeclampsia
is a multi-organ disease affecting liver, kidneys and the central
nervous system and can in severe cases progress to organ failure
(eclampsia). At present, there is no cure except for inducing birth,
often prematurely [3].
While it seems relatively straightforward to explain the narrow
human birth canal as an unavoidable evolutionary constraint, this
kind of interpretation seems invalid for hypertension-induced
problems during pregnancy. It would seem incomprehensible that
the fetus harms its pregnant mother while being so intimately and
obligatorily dependent on maternal health, both before and after
birth. And even if any genetic tendencies for fetuses to increase
maternal blood pressure would have arisen during our evolution-
ary past, it seems puzzling why natural selection has not removed
such fitness-reducing traits in our hunter-gatherer ancestors. The
alternative explanation that preeclampsia and other hypertension-
related pregnancy complications are mostly a modern affluent
society problem does not hold either, because preeclampsia is also
prevalent in developing countries where there is little access to
modern health care [2,4]. Despite many studies that have
identified proximate mechanisms in the etiology of preeclampsia
[2,5–7], much of the causal variation for hypertensive disorders of
pregnancy remains unknown, suggesting that this health problem
also needs a broader explanation. Such explanations can take two
non-mutually exclusive forms in that they can focus either on the
proximate physiological mechanisms, or on the evolutionary forces
of natural selection that have shaped human pregnancies. In this
paper we use the latter type of approach.
Parent-offspring conflict (POC) theory [8] hypothesizes that it is
in the genetic interests of a focal offspring to try – within limits – to
extract more resources than the mother is selected to provide, and
in her interest to provision her resources more equally between
current and future offspring. Many autosomal genes have been
implicated as being involved in POC interactions [9–11], but also
imprinted genes may be involved in the pathogenesis of
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hypertensive disorders of pregnancy [12–14]. The theory main-
tains that there is an interval of fetal-provisioning where the
maternal and paternal interests are not aligned because the father
of the focal fetus has a probability of less than 100% of also
fathering the focal mother’s next child, owing to serial monogamy
or varying degrees of promiscuity [12]. This implies that paternal
genes expressed in the placenta have been under consistent
selection to express phenotypes that somehow increase maternal
blood pressure as this would generally enhance fetal resource
provisioning via the mother-infant circulation interface [15,16].
Such genes would be particularly likely to succeed if they would be
able to silence the placental expression of maternal alleles, but that
inevitably induces selection for opposite maternal imprints at
complementary loci because a mother is symmetrically related to
all her children. In normal pregnancies these maternal/paternal-
specific imprinting effects would be expected to reach a balance
that produces a healthy offspring while preserving maternal health.
A substantial number of imprinted genes with opposite parent-of-
origin effects on embryo provisioning are now known, both in
humans and in mice [14,17,18] and other studies show that
disruptions to the balance of these genomic imprints can have
severe health consequences [19–22].
General explanations for hypertensive disorders of pregnancy
associated with POC would be most compelling if it could be
shown that milder forms such as pregnancy-induced hypertension
(PIH) are beneficial for offspring health, as that would imply that
the overall benefits of hypertension during pregnancy may balance
or even exceed the negative costs of the more severe forms such as
preeclampsia, rather than preeclampsia imposing a population-
level genetic load. Several studies have demonstrated negative
effects of hypertensive disorders on developing fetuses and
newborns [23–27] and on subsequent offspring health [28,29] in
spite of increases in birth weight [16], but outcomes are not always
pathological. Although not the focus of earlier studies, Symonds
[30] found lower average perinatal mortality of babies born to
mothers with PIH, and others reported improved health in
offspring exposed to any kind of hypertensive disorder of
pregnancy (i.e. after pooling PIH, preeclampsia, eclampsia),
particularly in small for gestational age neonates [31,32].
However, no previous studies have focused on PIH specifically
while separating it from the various milder and more severe forms
of hypertensive pregnancy disorders in order to investigate
perinatal mortality and the long-term impact on offspring health.
Moreover, PIH throughout pregnancy may have different effects
depending on when it occurs, due to changing fetal demands and
natural background variation in the typical maternal blood
pressure [16] (Fig. 1). The capacity of maternal blood supply
(i.e. veins and arteries that connect fetal-maternal tissues, Fig. 1) is
largely determined early in pregnancy (first 20–22 weeks) when
placental invasion of the endometrium and modification of the
spiral arteries takes place [12]. This suggests that the effects of PIH
on maternal-fetal interactions and ultimately offspring health may
vary depending on its occurrence and timing throughout
pregnancy, yet no study has investigated this before. Here, we
examine these relationships by utilizing the national health
registries in Denmark, which provided us with data on .1.8
million births from 1977–2007 and diseases diagnosed within .5
million people from 1977–2009.
Results
Using Cox regression that adjusted for potentially confounding
effects, we estimated the risk of infant mortality and diseases after
birth, depending on the occurrence of maternal PIH by trimester
(Fig. 2A) or preeclampsia. In the PIH analysis, three dummy
variables coded for the continuous and intermittent presence or
absence of elevated blood pressure in trimesters 1, 2 or 3. For
example, the ‘PIH in trimester 19 dummy variable (total PIH
diagnoses = 678, Fig. 2A) included PIH diagnoses that started
(light grey bars, n=10 and n=644) or only occurred (dark grey
bar, n=24) in trimester 1, whereas the ‘PIH in trimester 29
dummy variable (total PIH diagnoses = 1568) included PIH
diagnoses that started (light grey bar, n=721), only occurred
(dark grey bar, n=193) or continued (light grey bars, n=10 and
n=644) into trimester 2. This ‘‘overlapping’’ design allowed risk
ratio comparisons between trimesters, while also adjusting for the
effects of PIH that continued across multiple trimesters. This
would not have been possible if we had only included the specific
diagnoses for each of the trimesters (dark grey bars, Fig. 2A).
Moreover, a trimester-specific analysis would have decreased
sample sizes to the point of producing unreliable Cox analysis
estimates (see Table S3), particularly for trimester 1. In the
preeclampsia analysis, only one binary dummy variable was
Figure 1. Typical patterns of placental-fetal growth, maternal
blood pressure and tissue interactions across the ,40 weeks
(i.e. trimesters 1,2 and 3) of human pregnancy. (A) Typical curves
of placental growth (blue), fetal growth (pink) and normal maternal
blood pressure (brown), approximated based on various sources [43–
46]. (B) Schematic diagram of trophoblast invasion (up to week 20–22)
that upscale fetal provisioning via the placental blood vessels and
tissues that are either 100% maternal (yellow/orange shades) or 50–50
maternal and paternal and thus genetically identical to the offspring
(blue shades) and where paternally imprinted genes can be expressed.
Maternal structures: MY: myometrium, DD: decidua or uterine lining
during pregnancy, SA: spiral arteries, IVS: intervillous space (contains
pool of maternal blood; red coloured). Fetal structures: CP: chorionic
plate, VT: villous tree (growth of VT’s (from left to right) is completed by
week 20–22). The genomic imprinting hypothesis for PIH assumes that
paternally imprinted genes expressed in the blue tissues can induce
enhanced maternal blood pressure via physiological and morphological
adjustments [15], unless maternally expressed genes in the yellow/
orange tissues induce compensating phenotypic effects to match this
fetal demand for increased resource provisioning [47].
doi:10.1371/journal.pone.0056821.g001
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needed to code for its presence as this diagnosis predominantly
occurred in trimester 3.
We found significant differences in infant mortality (Fig. 2B)
depending on the trimester in which PIH occurred, relative to
normotensive pregnancies. If PIH occurred in trimester 3, risk of
infant mortality was doubled (hazard or risk ratio (RR) = 2.06,
95% CI=1.37–3.09, P,0.001, Fig. 2C (right panel)), similar to
the increased mortality risk experienced when more severe forms
occur (i.e. preeclampsia, RR=2.37, 95% CI=1.27–4.44,
P=0.006). For PIH in trimester 2, the risk ratio was ,1 indicating
a lower risk of infant mortality. This difference was not significant
when compared to normotensive pregnancies in the same
Figure 2. Classification of the distribution of women diagnosed with pregnancy-induced hypertension (PIH) included in our study
(A). PIH either only occurred across one trimester (1, 2 or 3; dark grey arrows) or across multiple trimesters (1–2, 2–3, 1–3; light grey arrows). Numbers
within arrows are sample sizes. Elevated blood pressure is registered as a specific diagnose code (Table S2) in the Danish National Patient Registry. As
women’s diagnoses were registered in our database with multiple in and out dates, this classification was the most accurate possible. (B) Distribution
of age at death across the first 30 years of life for Danish offspring born between 1977 and 2007. Deaths in total were 3,118, of which 34.51% are
accounted for in the first year after birth, and 22.5% in the following 2–5 years of life. Mortality in the first year of life was mainly due to perinatal
complications (21.2%) and congenital malformations (38.5%). (C) Kaplan-Meier survival plots of offspring mortality in the first year of life. Red lines
represent cumulative mortality of offspring born to mothers who experienced pregnancy-induced hypertension (PIH) in trimester 2 (left panel) or 3
(right panel), relative to those with normotensive pregnancies (grey lines; identical in both plots). Lines represent averages (solid) 695% confidence
intervals (dashed) in trimester 2 (P = 0.17) and in trimester 3 (P,0.001). For offspring born from pregnancies with PIH, the difference in risk of
cumulative mortality between trimester 2 and 3 is significantly different (P = 0.0028). Survival curves for trimester 1 could not be calculated as no
offspring died who were born to mothers with PIH in trimester 1 (n= 678). Data cover the period of registration between 1979–2009.
doi:10.1371/journal.pone.0056821.g002
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trimester (RR=0.44, 95% CI= 0.14–1.41, P=0.17, Fig. 2C (left
panel)), but was significant when compared to the survival curve
for children born to mothers suffering from PIH in trimester 3
(P=0.0028). All infants of the 678 mothers with PIH in trimester 1
survived the first year of life. This zero value for the risk of infant
mortality precluded that formal Cox regression coefficients (risk
ratio, P-value) could be obtained in comparison with normotensive
pregnancies, but suggests that PIH-induced mortality is extremely
low when it arises early in pregnancy. Mortality beyond the first
year of life was not included as most infant mortality was observed
during the perinatal period (Fig. 2B).
Our next objective was to estimate the risk of infant disease after
birth with up to 27 years of follow up, depending on the
occurrence of the same set of pregnancy-related complications as
above. We found largely consistent changes in risk ratio direction
for the 14 disease groups considered (Fig. 3, Table S1), depending
on when or what type of hypertension occurred throughout the
pregnancy. The highest risks for disease were observed when
mothers had preeclampsia, with risk of being diagnosed signifi-
cantly enhanced across all 14 disease groups in congruence with
results from Wu et al. [28]. If PIH occurred in trimester 3 (but
without advancing to preeclampsia), the direction of disease risk
was also consistently positive (12 out of 14) suggesting a moderately
increased overall risk for disease, with risks in five of the groups
being significantly enhanced. This trend continued for PIH having
been diagnosed in trimester 2, but with only two of the disease
groups having significantly enhanced risk ratios compared to
normotensive pregnancies.
In sharp contrast with the increased risk of most diseases due to
hypertension in trimester 2 and 3, PIH occurring in trimester 1
appears to have the opposite effect on offspring health, with risk of
disease being reduced in 12 of the 14 main disease groups, relative
to normotensive pregnancies (Fig. 3). In spite of the rather modest
number of PIH diagnoses that occurred in trimester 1 (n=678;
Fig. 2A), two of these were significant, including a decreased risk
for skin (RR=0.53, P,0.05) and respiratory (RR=0.80, P,0.05)
diseases (cf Table S1). This suggests that developing fetuses will
only gain benefits of maternal hypertension if it starts early during
pregnancy when the fetal-maternal connections in the placenta are
being formed. We further used a meta-analysis approach where
coefficients and standard errors from the 14 main Cox regressions
were used in a Student t-test (for dependent samples) to compare
whether PIH-in-trimester-2 risk ratios were significantly larger
than PIH-in-trimester-1 risk ratios. This resulted in 14 P values,
which were then combined into an overall P value using weighted-
Z and Fisher’s approach in the survcomp package in R. This
showed that the average disease risk difference between trimester 1
and 2 was highly significant (P,0.001 in all methods (Fig. 4))
confirming that PIH has vastly different effects on developing
fetuses and the subsequent general health of children depending
on timing of exposure.
Discussion
Our results indicate significantly reduced first year mortality
and later-life disease risks for offspring born to mothers with PIH
Figure 3. Risk of being diagnosed with a disease belonging to one of the 14 disease groups for offspring born to mothers with
pregnancy-induced hypertension (PIH) in trimester 1, 2 or 3, or preeclampsia from week 20 onwards. Risk ratios and P values (*P,0.05,
**P,0.01, ***P,0.001) come from Cox regressions and are relative to women with normotensive pregnancies (controls). Logged risk ratios represent
increased (above 0) or decreased (below 0) risk of being diagnosed with disease across the ages of 1–27 years. The fourteen disease groups are listed
towards the upper right with the same shading as in the bar plots. The plot is based on numbers provided in Table S1.
doi:10.1371/journal.pone.0056821.g003
Hypertension and Parent-Offspring Conflict
PLOS ONE | www.plosone.org 4 February 2013 | Volume 8 | Issue 2 | e56821
early in pregnancy, whereas PIH in later trimesters increases these
risks, so they come to approach those connected with preeclampsia
when PIH occurs in trimester 3. A proximate explanation for this
shift may be that fetuses that became endowed with slightly
insufficient placentas have ways to counter the threat of remaining
undernourished by increasing maternal blood pressure to drive
more nutrients across the fetal-placental barrier [12]. This would
be an expression of parent-offspring conflict (which also may apply
to non-imprinted autosomal genes subject to POC), but one
conditional on a suboptimal start in fetal life that would - from
a paternal gene perspective - justify a shift in the provisioning
balance between mother and child in spite of enhanced risks for
both maternal and offspring health. As most fetal growth occurs in
the last half of trimester 2 and in trimester 3 (and most placental
growth in trimester 1, Fig. 1), such enforced catch-up growth
would fit our observation that pregnancies with PIH result in
somewhat (2.1%) lower average birth weight in comparison with
normotensive pregnancies (3,469 versus 3,544 g, Student’s t-test
P,0.001, Table 1). This average remains firmly within the range
that is considered appropriate for gestational age, similar to the
even lower average birth weight (3,361 g) of babies born to
preeclamptic mothers (Table 1, Student’s t-test P,0.001 in
comparison with the PIH cohort). While these birth weight
differences are of some interest in their own right [16], they were
included as covariates in our analyses and thus accounted for in
the results presented in Figs. 2, 3, 4 and Table S1. The fetal under-
nutrition hypothesis does therefore not explain why PIH in
trimester 1 brings survival and later health benefits to children,
relative to normotensive pregnancies.
Another possible proximate explanation for the observed shift in
decreased to increased offspring disease and mortality risk is that
the mechanisms (and thus subsequent health effects on offspring)
underlying early vs. late occurring maternal PIH differ. For
example, Yuan et al. [33] suggest that the cascading set of events
(i.e. early insufficient shallow cytotrophoblast invasion triggering
placental chemical releases that damage maternal endothelium
causing increased maternal blood pressure) that ultimately triggers
onset of above average maternal blood pressure should not
become manifest as clinical symptoms until after trimester 1. This
might suggest that the cause of PIH in trimester 1 is not linked to
insufficient cytotrophoblast invasion but to a different process that
leads, hemodynamically (via blood flow/pressure), to a healthier
offspring. PIH in trimester 1 is unlikely to be linked to general
blood-pressure problems, as we excluded mothers with any form of
pre-existing hypertension. Currently, much remains to be discov-
ered on how the various hypertensive disorders of pregnancy
develop and interact throughout pregnancy.
From an evolutionary perspective, the original hypothesis by
Haig [12] predicts that POC affects maternal blood pressure
throughout pregnancy. Milder forms of PIH would then reflect
a balance between fetal factors inducing slightly higher blood
pressure (and gaining advantages from these without large
maternal costs) and maternal factors decreasing blood pressure.
More severe forms of PIH were hypothesized to be due to
insufficient blastocyst invasion early in pregnancy (week 20–22,
Fig. 1) resulting in conflict over limited resources later in
pregnancy, which is more damaging for both mother and
offspring, in spite of fetuses also benefitting from increased
provisioning [12,16]. Damaging effects for mother’s own health
include increased risks of mortality [34], morbidity [35] and health
problems during subsequent pregnancies [36]. Our results suggest
that PIH in the first 13 weeks of pregnancy may enhance fetal
blastocyst invasion leading to a more accessible maternal blood
supply later in pregnancy. The timing of PIH may therefore be
linked with Darwinian fitness so that natural selection may be
responsible for the maintenance of these disorders in modern
humans.
If genetic variation related to POC [12,20] exists, PIH in
trimester 1 might be achieved when imprinted placental genes of
both parents are somewhat overexpressed, but without paternal
Figure 4. Interaction plot of the risk (exponentiated risk coefficients) of being diagnosed within the first 27 years of life for
offspring born to mothers with pregnancy-induced hypertension (PIH) in either trimester 1 (left) or trimester 2 (right). Coefficients
,1 indicate decreased risk and.1 increased risk of being diagnosed with disease. Grey lines represent the 14 main disease groups and the red line is
the overall average, which was significantly higher (P,0.001) for offspring born to mothers with PIH in trimester 2 compared to trimester 1. The plot
is based on numbers from Table S1.
doi:10.1371/journal.pone.0056821.g004
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genes imposing challenges that the maternal genes cannot meet so
placental growth will be a balanced function of both forces.
However, if PIH first occurs later in pregnancy, this may represent
resource demands by paternal genes in response to suboptimal
placental investment early in pregnancy, which would be
consistent with the shift from enhanced to compromised offspring
health depending on the timing of PIH. This appears consistent
with recent molecular and genomic studies that have discovered or
confirmed many genes with parent-of-origin effects on fetal growth
[18] and blood pressure [37] and even genes related to
invasiveness of the placenta in trimester 1 [38]. Our present
results suggest that systematic gene-expression and methylation
studies of placentas across a wide range of normal and slightly
abnormal pregnancies would be a valuable contribution to
understanding the etiology of PIH from a POC perspective,
rather than focusing only on mechanistic explanations of the
separate syndromes.
In conclusion, our study provides epidemiological evidence of
health benefits provided by the milder form of a condition that is
generally considered maladaptive, and offers a clearer picture of
why hypertensive disorders in pregnancy may continue to persist
in modern humans. The results of our study confirm that large
public health databases are useful for testing questions inspired by
evolutionary theory [39–41] and for generating novel questions




The ongoing Danish National Patient Registry (DNP) has
collected and electronically stored all diseases diagnosed within
hospitals in the Danish population since 1977. From 1977–1993
all diagnoses were coded by the International Classification of
Diseases, eighth revision (ICD-8) and from 1994 onwards by the
tenth revision (ICD-10) (http://www.medinfo.dk/sks). Unique
personal identification numbers (PNRs also known as anonymized
‘Central Person Register’ or CPR numbers) were used to link the
Table 1. Baseline statistics of the parents and their offspring included in our study.
normotensive PIH preeclampsia all
number of births 704013 9788 44531 758524
maternal, n 367709 8607 38499 413594
age at delivery (years) 28.61 (4.63) 29.21 (5.11) 27.91 (5.11) 28.57 (4.67)
parity (sibling number) 1.68 (0.90) 1.67 (0.90) 1.53 (0.82) 1.68 (0.90)
BMI (2003 onwards) 23.79 (4.54) 26.61 (5.98) 26.15 (5.87) 23.92 (4.65)
smoking (1993 onwards), n (%) 29774 (4.23) 315 (3.22) 1789 (4.02) 31878 (4.20)
previous induced abortions 0.14 (0.44) 0.18 (0.49) 0.21 (0.54) 0.15 (0.45)
previous spontaneous abortions 0.13 (0.42) 0.18 (0.51) 0.17 (.0.49) 0.13 (0.42)
education, n (%)
0–12 years 31246 (4.44) 547 (5.59) 2586 (5.81) 34379 (4.53)
12–15 years 114992 (16.33) 1811 (18.50) 9696 (21.77) 126499 (16.68)
15–17 years 283038 (40.20) 4089 (41.78) 18590 (41.75) 305717 (40.30)
17–20 years 215401 (30.59) 2740 (27.99) 11329 (25.44) 229470 (30.25)
20–22 years 56003 (7.95) 572 (5.84) 2210 (4.96) 58785 (7.75)
22+ years 3333 (0.47) 29 (0.30) 120 (0.27) 3482 (0.46)
paternal
age at delivery 31.32 (5.56) 31.68 (5.81) 30.64 (5.92) 31.28 (5.59)
maternal/paternal
combined annual income 201400 360000 334000 211500
births
male, n (%) 360591 (51.22) 5026 (51.35) 23285 (52.29) 388902 (51.27)
female, n (%) 343422 (48.78) 4762 (48.65) 21246 (47.71) 369430 (48.70)
birth weight (grams) 3544 (508.62) 3469 (573.22) 3411 (685.73) 3535 (522.53)
gestational length (days) 279.3 (10.84) 277.8 (11.48) 275.0 (14.77) 279.1 (11.17)
BMI at birth 14.40 (2.01) 14.25 (1.98) 14.34 (2.04) 14.40 (2.01)
Apgar5 score 9.89 (0.61) 9.82 (0.77) 9.78 (0.78) 9.88 (0.62)
Maternal variables are divided into mothers with normotensive (control) pregnancies relative to those who experienced pregnancy-induced hypertension (PIH) or
preeclampsia. Values are means (6 SD) except where indicated otherwise. P-values from t-tests between normotensive and PIH/preeclampsia cohorts were all between
P= 4.867e214 and P,2.2e216, except for parity differences between normotensive and PIH mothers, which were not statistically different (P=0.135). All data are
based on records of the Danish National Patient Registry, spanning the years 1979–2007. Apgar5 score is an evaluation of the neonate’s health five minutes after birth
on a scale from 0 to 10, where 10 indicates best possible health. Woman with PIH were on average slightly older, had more previous spontaneous and induced
abortions, higher family income, and higher BMI compared to the rest of the sample. These variables were all included in the Cox regressions so their effects were
partialled out. Because BMI was only recorded from 2003 onwards, it was not included as a covariate in this analysis but was included in a smaller analysis, of which the
results were consistent in direction and magnitude to those in Table S1, suggesting that BMI is not a major explanatory variable.
doi:10.1371/journal.pone.0056821.t001
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DNP data with a number of other population registers including
the Danish Civil Registration System, the Fertility Database and
the Cause of Death registry. We obtained approval for our study
from the Danish Data Protection Agency (www.datatilsynet.dk),
the Danish National Board of Health (www.sst.dk) and Statistics
Denmark (www.dst.dk), where the latter was the direct data
provider. All data were previously de-identified and hosted on
a secure computer by Statistics Denmark.
The Maternal Sample
We extracted information on all mothers giving birth to
singletons from 1 January 1977 to 31 December 2007
(n=1,004,129 mothers, n=1,872,192 births, n=7,488,768 off-
spring diagnoses recorded since 1977) and excluded twin and
higher order births (n=61,180 births). The sample was further
reduced to 413,594 after excluding mothers due to: missing values
for gestation length in 1977–1978, mismatches between maternal
birth-related diagnoses and corresponding births due to short
interbirth intervals, birth information erroneously matching with
several biological mothers, and having a previous diagnosis of
potential impact in PIH or preeclampsia: hypertension, diabetes,
hypotension, purpura (purple discolorations under the skin due to
inflammation), some circulatory diseases (ischaemic heart diseases;
ICD-8/ICD-10 codes 41309, 41009, 41199, 41409/DI20–25) and
some diseases of the genitourinary system and liver (insufficient
kidney; ICD-8/ICD-10 codes 59309, 59319–59327/DN17, liver
functioning; ICD-8/ICD-10 codes 57008–57009/DK72). The
final sample (n=413,594 mothers, n=758,524 singleton births,
n=3,537,525 offspring diagnoses recorded since 1977, Table 1)
included women with a singleton birth who were either diagnosed
with pregnancy-induced hypertension (without proteinurea; ICD-
8/ICD-10 codes 63700/DO13, DO139; n=9,788 births to 8,607
mothers), or with preeclampsia (ICD-8/ICD-10 codes DO14,
63703/DO140, 63704/DO141, 63709/DO149; n=44,531 births
to 38,499 mothers). The remaining cases were normotensive
singleton pregnancies (n=704,013 births to 367,709 mothers).
Women Defined as having Pregnancy-induced
Hypertension (Without Proteinuria)
Of the women defined as having pregnancy-induced hyperten-
sion (PIH) we included only those with the specific ICD-10
diagnoses DO13 and DO139 (ICD-8 63700, Table S2), but we
excluded women from this category if PIH developed into
preeclampsia later in pregnancy. PIH can be diagnosed in women
who do not have protein in the urine but have a blood pressure in
the range of 130–139/85–89 mmHg at any stage during
pregnancy.
Denmark has a publicly funded health care system that is freely
available to the entire population. Every pregnant Danish woman
therefore has approximately three scheduled meetings with her
general practitioner (GP) and about six meetings with her midwife.
At each meeting her blood pressure is measured and urine samples
analysed (with urine dip stick). Since PIH is one of the potential
precursors of preeclampsia (but not necessary leading to it),
women with PIH are subsequently monitored more frequently by
their GP or midwife (except when PIH disappears). This could
explain why there is a higher incidence of women with only a few
days hypertension and fewer cases with a consistent PIH diagnose.
PIH is registered but rarely treated, which suggests that not all
women with gestational hypertension are recorded with this
diagnosis at the hospital, leading to an unknown amount of under-
reporting for PIH. The specificity of the Danish National Patient
Registry has been validated as being high in general, but a control
study indicated that PIH is indeed underestimated [42]. We note,
however, that underreporting will tend to make the outcomes of
our analyses conservative as it will make the difference between
early PIH and normotensive pregnancies less pronounced.
To assess the risk of PIH on subsequent health of offspring, we
created three dummy variables that marked whether PIH
occurred in trimester one, two and three (Fig. 2A) and used
PNRs to collect information on offspring health (mortality and
disease) after birth. While the classification of a pregnancy into
a trimester scheme is pragmatic clinical practice, it does not reflect
the biological development of a pregnancy very well. For example,
during the first few weeks of a pregnancy the fetus invests heavily
in initial growth and development of the placenta [12]. During this
period, the spiral arteries (fetal blood veins) are forming (Fig. 1), so
if strong connections with maternal tissue are made early on
(perhaps enhanced via increased blood pressure), this could give
the fetus a good start for the rest of pregnancy. In week 8 the fetus
weighs around 8 g with the placenta accounting for 85% of this
[12]. After week 22 the development of the maternal blood supply
to the placenta is completed and at this point in time the fetus
starts gaining weight more rapidly and begins to accumulate body
fat. In week 38, fetal weight is estimated to be 3,250 grams on
average, whereas the placenta now only accounts for just 12% of
this (Fig. 1) [12].
Women Defined as having Preeclampsia
Women were diagnosed with different degrees of preeclampsia
(Table S2) that included unspecified preeclampsia (ICD-8/ICD-10
codes 63709/DO149), mild preeclampsia (63703/DO140) or
severe preeclampsia (63704/DO141). We grouped these into one
preeclampsia category for analysis. To be diagnosed with pre-
eclampsia during pregnancy, women must be measured twice as
having a blood pressure $140/90 mmHg after 20 weeks of
gestation combined with high amounts of protein in the urine
(proteinurea) [2]. Severe preeclampsia is defined by a blood
pressure $160/110 mmHg accompanied by proteinurea, head-
aches or other cerebral and visual disturbances.
Disease Classifications Used for Offspring Health
Using the PNR (CPR) numbers from the 758,524 offspring born
to 413,594 mothers, we extracted information on offspring
mortality (deaths recorded within one year after birth) and
diseases these offspring were diagnosed with from birth (years
ranged from 1979–2007) until 31 December 2009. Offspring
diseases were grouped according to 14 standard disease classifica-
tions (Table S1) that the Danish National Board of Health
maintains (www.medinfo.dk). These 14 classes capture essentially
all diseases that hospitals in Denmark diagnose except for
accidents, which we excluded because no relationships with
conditions in the womb were to be expected.
Assessing the Risk of Offspring Mortality and Disease
We used Cox proportional- hazard regression for survival data
in R version 2.13.2 to estimate risk of mortality (up to 1 year after
birth) and disease (up to 27 years after birth, Table S1) for
offspring born from pregnancies that were defined as normoten-
sive, with PIH or preeclampsia (Table S2). Mortality rates beyond
year one for offspring born to hypertensive mothers were too low
(Fig. 2B) to be able to obtain reliable regression coefficients. We
used Kaplan-Meier plots to investigate survival of offspring born to
normotensive mothers compared to mothers with PIH in trimester
2 and 3 (Fig. 2C). We excluded offspring who died of accidental
causes and diagnoses that did not specifically refer to offspring
(obstetric; ICD-8/ICD-10 codes 63000–67809/DO00–99, peri-
natal; ICD-8/ICD-10 codes 76000–77999/DP00–99, injury and
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external causes; ICD-8/ICD-10 codes 80000–99999/DS00-
DT98). We included a birth cohort variable to account for
temporal variation in predictor variables.
General Procedures for Statistical Analysis
All analyses were adjusted for the following potentially
confounding maternal/paternal effects: previous spontaneous or
induced abortions, parity (how many live offspring a woman
previously gave birth to), average parental age at birth, combined
family income, mothers education level. Family income was
calculated as the average of general income before taxes (across
the years 1979–2007) between the mother and father (also in cases
where the parents lived separately). Maternal education was
recorded in years, beginning from year 1980. We also included the
following covariates to adjust for possible confounding offspring
effects: sex of the baby, birth weight and length (adjusted for
gestational age), year of birth in five-year cohorts, and Apgar5
score. Apgar5 is a general health evaluation made by the midwife
or doctor of the neonate’s skin colour, breathing, reflexes,
heartbeat and muscle tone five minutes after birth. Each factor
can give two points, so the score is between 0–10, where 10 is
given to the most healthy appearing babies. To account for
possible parabolic effects, quadratic terms for maternal and
paternal age were included, but subsequently removed as these
were non-significant in all analyses. Scatterplots of the different
variables were used to visualize and exclude any outliers in the
dataset. The cut-offs for gestational length were set to a minimum
of 140 days (20 weeks) and a maximum of 315 days (45 weeks).
The cut-offs for birth weight were set to a minimum of 200 grams
and a maximum of 6,500 grams.
Model diagnostic procedures were run for the Cox regressions
including checking for violation of the assumption of proportional
hazards, for disproportional data, and for nonlinearity in the
relationship between the log hazard and the covariates. All are
standard tests used to check whether a fitted Cox regression
adequately describes the data. Tests for proportional hazards were
based on scaled Schoenfeld residuals and indicated no violation of
proportional hazards for any of the covariates. Potential outliers
were removed after identifying them by comparing dfbeta values
to the regression coefficients obtained from the Cox regressions.
No covariates displayed significant nonlinearity as confirmed by
plotting martingale residuals against covariates from the Cox
regression. All significant P values were Bonferroni corrected.
Supporting Information
Table S1 Risk of disease (from birth up to 27 years of age) within
the 14 main disease groups depending on whether offspring were
born to mothers with PIH (trimester 1, 2 or 3) or preeclampsia
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analyses refer to the number of times (out of 5000 permutations) in
which the RR pseudo-estimate was equal to or less than the
originally estimated RR, with ns indicating significant P values
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